Scilex Holding Co

Scilex Holding Company (Nasdaq: SCLX) is a commercial-stage specialty pharmaceutical company focused on non-opioid pain management. The company reached the public markets through a merger with Vickers Vantage Corp. I, a blank-check vehicle sponsored by Vickers Financial Group that completed its IPO in 2021. The business combination closed in December 2022, and the combined entity now trades on Nasdaq under the SCLX ticker. Scilex operates in the healthcare and specialty pharmaceuticals sector, with approved products targeting acute and chronic pain conditions. A Form 10-Q filed in July 2021 represents an early reporting milestone in the deal's progression toward closing. Sign up for SpacDesk to access full filing histories, transaction analytics, and real-time data on SCLX and the broader SPAC market.